INV-102 Eyedrops for Pink Eye

Recruiting in Palo Alto (17 mi)

+11 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 2

Waitlist Available

Sponsor: Invirsa, Inc.

Prior Safety Data

Trial Summary

What is the purpose of this trial?Phase 2, randomized study to assess topically administered eyedrops of INV-102 compared to vehicle during 1-week dosing in participants with Acute Infectious Keratoconjunctivitis (AIK). Participants will return for a follow up visit 1 week after end of treatment.

Eligibility Criteria

Adults over 18 with moderate redness and at least mild discharge in one eye, diagnosed with Acute Infectious Keratoconjunctivitis (AIK), commonly known as pink eye. Participants should not have other conditions that would exclude them from the study.

Inclusion Criteria

I am 18 years old or older.

I have been diagnosed with AIK, with noticeable redness and some discharge in at least one eye.

Exclusion Criteria

Do you have moderate to sever redness in your eye?

Are you experiencing some discharge in your infected eye?

I have or might have a fungal eye infection.

+12 more

Participant Groups

The trial is testing INV-102 eyedrops against a placebo (vehicle) to see if they're effective for treating AIK. It's a phase 2 study where participants are randomly chosen to receive either the test medication or placebo for one week.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: INV-102 0.7% Three Times per Day (TID)Experimental Treatment1 Intervention

INV-102 ophthalmic solution administered for about 1 week

Group II: Vehicle TIDPlacebo Group1 Intervention

INV-102 ophthalmic solution administered for about 1 week